PHASE-1 CLINICAL-TRIAL OF A 3-DAY DIVIDED DOSE SCHEDULE OF IFOSFAMIDE (NSC109724)

被引：14

作者：

NELSON, RL

CREAVEN, PJ

COHEN, MH

FOSSIECK, BE

机构：

[1] VET ADM HOSP,NCI MED ONCOL SECT,WASHINGTON,DC 20422

[2] VET ADM HOSP,MED SERV,WASHINGTON,DC 20422

来源：

关键词：

D O I：

10.1016/0014-2964(76)90241-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：195 / 198

页数：4

共 9 条

[1]

AHMANN DL, 1974, CANCER CHEMOTH REP 1, V58, P861

[2]

BREMNER DN, 1974, CANCER CHEMOTH REP 1, V58, P889

[3]

COHEN MH, 1973, P AM ASSOC CANC RES, V14, P64

[4]

COHEN MH, 1975, CANCER CHEMOTH REP 1, V59, P751

[5]

CREAVEN PJ, 1974, CLIN PHARMACOL THER, V16, P77

FRIEDMAN, OM ;

BOGER, E .

[7]

SCHEEF W, 1972, 7 P INT C CHEM PRAG

[8]

SLAVIK M, COMMUNICATION

[9]

VANDYK JJ, 1972, CANCER RES, V32, P921